Arteriosclerosis
Not recruitingStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
- Disease:Arteriosclerosis
- Substances:Inclisiran
Spain- Participants:18–64 years · 65+ years
- Substances:Inclisiran
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Spain1 clinical trial in Ronda, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on atherosclerotic cardiovascular disease prevention are underway. These studies aim to evaluate innovative therapeutic approaches for reducing major adverse cardiovascular events in high-risk patients.
The research explores new therapeutic options for patients at risk of serious cardiovascular complications, including myocardial infarction and ischemic stroke, with a focus on preventive medicine approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.